Castor Videos

At this year’s CNS Summit, Castor achieved a remarkable feat by winning the AI Demo Awards. Watch more to hear on-site updates from Derk!

As the world works towards a future of AI-assisted solutions, we believe that everyone who is involved in the process of clinical trials should have access to valuable tools and be able to leverage these emerging technologies.

Decentralized technologies are transforming clinical trials by addressing patient recruitment and engagement challenges.

Decentralized technologies are transforming clinical trials by addressing patient recruitment and engagement challenges.

Listen to our CEO & Founder, Derk Arts, as he reflects on lessons learned from the BIO panel discussion and what to expect at DIA.

As the adoption of real-world evidence (RWE) in healthcare continues to grow, and with the FDA embracing these trials more and more, researchers have come to appreciate the significance of establishing uniform approaches for evaluating and analyzing real-world data (RWD).

As the adoption of real-world evidence (RWE) in healthcare continues to grow, and with the FDA embracing these trials more and more, researchers have come to appreciate the significance of establishing uniform approaches for evaluating and analyzing real-world data (RWD).

As the adoption of real-world evidence (RWE) in healthcare continues to grow, and with the FDA embracing these trials more and more, researchers have come to appreciate the significance of establishing uniform approaches for evaluating and analyzing real-world data (RWD).

As the adoption of real-world evidence (RWE) in healthcare continues to grow, and with the FDA embracing these trials more and more, researchers have come to appreciate the significance of establishing uniform approaches for evaluating and analyzing real-world data (RWD).

As we kick-off 2023 with a refreshed mindset, we take inventory of what is important and focus on our goal to continuously make sure that we are maximizing the impact of data on the global disease burden with more inclusive, patient-friendly trials.